Medipal Holdings Corp
TSE:7459

Watchlist Manager
Medipal Holdings Corp Logo
Medipal Holdings Corp
TSE:7459
Watchlist
Price: 2 901 JPY -0.63% Market Closed
Market Cap: ¥600.4B

Medipal Holdings Corp
Investor Relations

Medipal Holdings Corp., a longstanding pillar in Japan’s healthcare and pharmaceutical distribution network, tells a story of efficiency and dedication to health. Born from a strategic merger in the late 20th century, Medipal has established itself as a key player in the intricate world of pharmaceutical and medical supply logistics. The company's operations are woven into the fabric of Japan’s healthcare infrastructure, where precision and reliability form the foundation of its success. By orchestrating the smooth flow of pharmaceuticals, medical devices, and health-related products from manufacturers to a myriad of healthcare facilities and retail outlets, Medipal plays a vital role in ensuring that medical professionals and patients alike have timely access to necessary products.

At the heart of Medipal's business model is a comprehensive supply chain that seamlessly connects an extensive network of partners. With sophisticated distribution centers operating as logistical powerhouses, Medipal leverages cutting-edge technology to optimize inventory management and delivery systems. This enables the company not only to drive efficiencies but also to create value by reducing costs and enhancing the speed and reliability of distributions. Revenue streams are generated primarily through distribution fees and the strategic management of logistics services. As Medipal continues to expand its reach and refine its operations, it remains steadfast in its commitment to being an indispensable ally in Japan's healthcare landscape, where reliability and trust are of paramount importance.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Shuichi Watanabe
Chief Compliance Officer, CEO, President & Representative Director
No Bio Available
Mr. Yuji Sakon
MD, GM of Administration Division & Director
No Bio Available
Mr. Toshihide Yoda
Senior MD of Investor Relations, GM of Business Development Department & Director
No Bio Available
Mr. Yasuhiro Choufuku
Executive VP & Director
No Bio Available
Mr. Shinjiro Watanabe
GM of Information Systems Management Division & Director
No Bio Available

Contacts

Address
TOKYO-TO
Chuo-Ku
2-7-15, Yaesu
Contacts
+81335175800.0
www.medipal.co.jp